AUG 08, 2018 02:35 PM PDT

Doxorubicin Causes Heart Toxicity by Immune System Disruption

Doxorubicin is a chemotherapy drug known by the brand name Adriamycin. It is widely used to treat ovarian, bladder, lung, thyroid and stomach cancers. Chemotherapy drugs are powerful and can have many side effects, both mild and severe. Doxorubicin can cause side effects such as chest pain, fever, cough, weight gain, nausea, hair loss, and unusual bruising. More severe side effects include problems such as birth defects, skin damage, the risk of new cancers, and heart problems such as damage and arrhythmia. A study recently published in the American Journal of Physiology-Heart and Circulatory Physiology shows how the drug causes a dose-dependent heart toxicity that can lead to congestive heart failure.

Credit: HaukelandDoxorubicin belongs to a group of chemotherapy drugs known as antineoplastic. These drugs interfere with the growth of cancer cells allowing them to be destroyed by the body, but this can also affect the growth of normal cells. Researchers from the University of Alabama Birmingham, led by Dr. Ganesh Halade, described how doxorubicin disrupts the metabolism that controls immune responses in the spleen and heart by studying mouse models. This metabolism is referred to as immunometabolism; two key players are immune-responsive enzymes known as lipoxygenases and cyclooxygenases. These two enzymes create a variety of lipid mediators that regulate immune cell responses. The disruption of immunometabolism is an essential contributor to the heart pathology caused by doxorubicin. The interruption of immunometabolism impairs resolution of inflammation and responses vital to heart maintenance and repair leading to advanced heart failure.

The study found the doxorubicin-induced fibrosis of the heart and increased apoptosis, known as programmed cell death, impaired heart pumping, and caused a wasting syndrome in the heart and the spleen. Wasting syndrome of the spleen is problematic since it acts as a reservoir of immune cells that respond to heart injury after an event like a heart attack. Specifically, doxorubicin poisoned a group of immune cell macrophages, causing the spleen to diminish in size and impaired host defense system. Doxorubicin also lowered levels of lipoxygenases and cyclooxygenases in the heart, which results in lower levels of lipid mediators that would usually resolve inflammation in the heart. An imbalance in cell-signaling molecules known as chemokines and cytokines also occurred with doxorubicin treatment, leading to further suppression of immune cells.

Doxorubicin use as a chemotherapy drug helps to treat various cancers but leads to heart and spleen toxicity that is problematic and can lead to long-term and potentially fatal complications such as congestive heart failure. But, knowledge of the mechanism behind this heart toxicity can lead to the development of strategies that can protect the spleen and heart during treatment with doxorubicin for cancer patients.

To read the study from UAB researchers in American Journal of Physiology-Heart and Circulatory Physiology click here. To learn more about chemotherapy drugs and how they work watch the video below!

United States National Library of Medicine

 

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
JUL 30, 2018
Immunology
JUL 30, 2018
Traumatic Childhood to Addiction, an Immune System Problem
Childhood adversity alters the immune system which contributes to increased risk of addiction as an adult....
AUG 13, 2018
Immunology
AUG 13, 2018
Silent Viruses Impact Microbe and Immune Cell Populations
Subclinical infections may alter the immune system and gut microbiota in the human host impacting how we respond to environmental stimuli like vaccines....
SEP 25, 2018
Videos
SEP 25, 2018
Heal Faster
Active patient vs passive patient...
OCT 29, 2018
Immunology
OCT 29, 2018
Immunity for All
A study published in Nature has shed light on the evolution of immune system genes across species with great detail at the single-cell level...
NOV 13, 2018
Immunology
NOV 13, 2018
Bacteria Offers Solution to Inflammation
A team of researchers surveys the mutualistic relationship between gut bacteria and host in regards to gut inflammation in zebrafish...
NOV 13, 2018
Immunology
NOV 13, 2018
Yin & Yang: The Duality of Cancer-Associated Fibroblasts in Pancreatic Cancer
Pancreatic Cancer is a devastating disease. Fifty-five thousand new patients were diagnosed this year in the United States (1). It is painful and usua...
Loading Comments...